Here are five things to know:
1. Last year, the market was valued at $60.2 billion.
2. The market is expected to increase at a compound annual growth rate of 3.7 percent from 2016 to 2024.
3. By 2024, the market is projected to hit $83 billion.
4. In 2015, two leading vendors, Pfizer and Purdue Pharma, had a market share surpassing 50 percent in 2015.
5. The growing prevalence of chronic diseases and the rising geriatric population are spurring market growths.
More articles on practice management:
St. Mary’s Regional Joint Replacement Center celebrates 8th year in business: 3 highlights
20 more things to know about orthopedic bundled payments — September 2016
This surgeon’s take on the hot topic sweeping orthopedics right now
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
